Orencia 250 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9KB5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $32,046
Award facts
- Contract value 100% obligated
- $32,045.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $32,045.82 to Amerisourcebergen Drug Corp (parent company: Cencora, Inc.) on January 7, 2026, for the supply of Orencia 250 mg vials. This competitively awarded, non-set-aside contract carries a firm fixed-price structure with an ultimate completion date of January 8, 2026. The work will be performed at Amerisourcebergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is executed under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Orencia (abatacept) is a biologic immunosuppressive medication commonly used in the treatment of rheumatoid arthritis and other autoimmune conditions. Through its extensive pharmaceutical distribution network and established relationship with the DLA, Amerisourcebergen continues to serve as a critical vendor for federal medical procurement, supplying specialty medications and medical commodities to support Defense Health Agency operations, U.S. Coast Guard, and other government healthcare systems. The company's capability to fulfill such orders demonstrates its role as a primary pharmaceutical distributor within the federal supply chain for military and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F9KB5?
SPE2DR26F9KB5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F9KB5 worth?
The government has obligated $32,046 on SPE2DR26F9KB5.
Is contract SPE2DR26F9KB5 an order under another contract?
Yes. SPE2DR26F9KB5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9KB5 competed?
The extent of competition for SPE2DR26F9KB5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award